Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Intestinal Research|January 14, 2025
Diagnostic performance of noninvasive tests for cytomegalovirus ileocolitis: a systematic review and meta-analysisThanaboon Chaemsupaphan, Onuma Sattayalertyanyong, Julajak LimsrivilaiExpert Review of Gastroenterology & Hepatology|January 27, 2025
Comprehensive care of ulcerative colitis: new treatment strategiesThanaboon Chaemsupaphan, Arteen Arzivian, Rupert W LeongJGH Open : an Open Access Journal of Gastroenterology and Hepatology|July 30, 2025
Self-Injection Satisfaction and Safety of CT-P17 (Yuflyma), a High-Concentration Adalimumab Biosimilar, in Patients With Crohn's Disease: A Cross-Sectional StudyFei Yang Pan, Thanaboon Chaemsupaphan, Sacha Cartwright, et al.Alimentary Pharmacology & Therapeutics|October 15, 2024
Review article: Optimisation of biologic (monoclonal antibody) therapeutic response in inflammatory bowel diseaseThanaboon Chaemsupaphan, Rupert W Leong, Niels Vande Casteele, et al.Clinical Drug Investigation|February 13, 2026
Cost-Consequences Analysis of Biologic Treatments for Moderate-to-Severe Crohn's Disease Using Real-World Transition Probability and Cost Data in ThailandThanaboon Chaemsupaphan, Onuma Sattayalertyanyong, Khachen Kongpakwattana, et al.World Journal of Gastrointestinal Endoscopy|July 18, 2025
Endocytoscopy in real-time assessment of histological and endoscopic activity in ulcerative colitisThanaboon Chaemsupaphan, Mohammad Shir Ali, Caroline Fung, et al.BMC Gastroenterology|February 1, 2020
Patient characteristics, clinical manifestations, prognosis, and factors associated with gastrointestinal cytomegalovirus infection in immunocompetent patientsThanaboon Chaemsupaphan, Julajak Limsrivilai, Chenchira Thongdee, et al.Crohn'S & Colitis 360|January 6, 2025
Development and Validation of a Scoring System to Predict 2-Year Clinical Remission in Ulcerative Colitis Patients on VedolizumabThanaboon Chaemsupaphan, Aviv Pudipeddi, Huiyu Lin, et al.Therapeutic Advances in Gastroenterology|January 22, 2026
Vedolizumab in inflammatory bowel disease: pharmacokinetics and the role of immunomodulator co-therapyAviv Pudipeddi, Thanaboon Chaemsupaphan, Arteen Arzivian, et al.World Journal of Gastroenterology|January 15, 2025
Vedolizumab serum trough concentrations with and without thiopurines in ulcerative colitis: The prospective VIEWS pharmacokinetics studyThanaboon Chaemsupaphan, Aviv Pudipeddi, Hui-Yu Lin, et al.Pageof 2